117,068 Shares in Select Medical Holdings Co. (NYSE:SEM) Bought by Moran Wealth Management LLC

Moran Wealth Management LLC acquired a new stake in shares of Select Medical Holdings Co. (NYSE:SEM) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 117,068 shares of the health services provider’s stock, valued at approximately $2,207,000. Moran Wealth Management LLC owned approximately 0.09% of Select Medical as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of SEM. Kingsview Wealth Management LLC purchased a new position in Select Medical in the 3rd quarter valued at about $1,927,000. JPMorgan Chase & Co. raised its holdings in shares of Select Medical by 9.7% during the third quarter. JPMorgan Chase & Co. now owns 416,299 shares of the health services provider’s stock valued at $14,516,000 after acquiring an additional 36,905 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new position in shares of Select Medical in the third quarter valued at approximately $1,592,000. Argent Capital Management LLC boosted its stake in shares of Select Medical by 79.8% in the fourth quarter. Argent Capital Management LLC now owns 55,144 shares of the health services provider’s stock worth $1,039,000 after acquiring an additional 24,471 shares during the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Select Medical by 2.0% during the third quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock worth $85,180,000 after purchasing an additional 46,880 shares in the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Price Performance

Select Medical stock opened at $16.99 on Wednesday. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The stock has a market cap of $2.19 billion, a P/E ratio of 10.29, a PEG ratio of 0.64 and a beta of 1.56. The company has a 50-day moving average price of $18.88 and a 200 day moving average price of $26.62. Select Medical Holdings Co. has a 12-month low of $16.20 and a 12-month high of $40.98.

Select Medical (NYSE:SEM) last released its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 EPS for the quarter, missing the consensus estimate of $0.29 by ($0.11). The firm had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.50 billion. Select Medical had a net margin of 3.23% and a return on equity of 14.04%. Sell-side analysts anticipate that Select Medical Holdings Co. will post 1.17 earnings per share for the current year.

Select Medical Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 13th. Stockholders of record on Monday, March 3rd will be issued a dividend of $0.0625 per share. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date of this dividend is Monday, March 3rd. Select Medical’s dividend payout ratio is presently 15.15%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. StockNews.com raised shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Friday, February 21st. Benchmark upgraded shares of Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price target on the stock in a research report on Monday, February 24th. UBS Group cut their price objective on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a report on Friday, January 3rd. Finally, Royal Bank of Canada lowered their target price on Select Medical from $47.00 to $23.00 and set an “outperform” rating on the stock in a report on Monday, February 24th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $27.25.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.